Wilms tumour
F Spreafico, CV Fernandez, J Brok, K Nakata… - Nature Reviews …, 2021 - nature.com
Wilms tumour (WT) is a childhood embryonal tumour that is paradigmatic of the intersection
between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non …
between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non …
Long-term care for people treated for cancer during childhood and adolescence
Worldwide advances in treatment and supportive care for children and adolescents with
cancer have resulted in a increasing population of survivors growing into adulthood. Yet, this …
cancer have resulted in a increasing population of survivors growing into adulthood. Yet, this …
Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …
JM Kocarnik, K Compton, FE Dean, W Fu… - JAMA …, 2022 - jamanetwork.com
Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD
2019) provided systematic estimates of incidence, morbidity, and mortality to inform local …
2019) provided systematic estimates of incidence, morbidity, and mortality to inform local …
Cancer statistics for adolescents and young adults, 2020
KD Miller, M Fidler‐Benaoudia… - CA: a cancer journal …, 2020 - Wiley Online Library
Cancer statistics for adolescents and young adults (AYAs)(aged 15‐39 years) are often
presented in aggregate, masking important heterogeneity. The authors analyzed population …
presented in aggregate, masking important heterogeneity. The authors analyzed population …
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …
Equity in cardio-oncology care and research: a scientific statement from the American Heart Association
D Addison, M Branch, AH Baik, MG Fradley… - Circulation, 2023 - Am Heart Assoc
Advances in cancer therapeutics have revolutionized survival outcomes in patients with
cancer. However, cardiovascular toxicities associated with specific cancer therapeutics …
cancer. However, cardiovascular toxicities associated with specific cancer therapeutics …
A joint international consensus statement for measuring quality of survival for patients with childhood cancer
RJ van Kalsbeek, MM Hudson, RL Mulder… - Nature medicine, 2023 - nature.com
The aim of treating childhood cancer remains to cure all. As survival rates improve, long-
term health outcomes increasingly define quality of care. The International Childhood …
term health outcomes increasingly define quality of care. The International Childhood …
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models
Aberrant alternative pre-mRNA splicing plays a critical role in MYC-driven cancers and
therefore may represent a therapeutic vulnerability. Here, we show that neuroblastoma, a …
therefore may represent a therapeutic vulnerability. Here, we show that neuroblastoma, a …
[HTML][HTML] European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
RJ van Kalsbeek, HJH van der Pal, LCM Kremer… - European journal of …, 2021 - Elsevier
Background Long-term follow-up (LTFU) care for childhood, adolescent, and young adult
(CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence …
(CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence …
Relative burden of cancer and noncancer mortality among long-term survivors of breast, prostate, and colorectal cancer in the US
Importance Improvements in cancer outcomes have led to a need to better understand long-
term oncologic and nononcologic outcomes and quantify cancer-specific vs noncancer …
term oncologic and nononcologic outcomes and quantify cancer-specific vs noncancer …